News

Accelerating Database Modernization with Cockroach Labs and AWS

Accelerating Database Modernization with Cockroach Labs and AWS

Collaboration Between Cockroach Labs and AWS

Cockroach Labs, a leader in cloud-native distributed SQL databases, is joining forces with Amazon Web Services (AWS) to revolutionize how businesses modernize their Windows-based applications and databases. By leveraging generative AI-powered transformation capabilities, this collaboration aims to rejuvenate outdated .NET applications that rely on traditional, monolithic legacy databases.

The Need for Modernization

As companies increasingly focus on cost-efficiency and superior infrastructure, the modernization of IT systems has become paramount. Many enterprises struggle to transition their .NET applications due to dependencies on outdated legacy databases, which are not designed to take full advantage of cloud benefits. These older systems often lack scalability, incur high maintenance costs, and fail to provide multi-region support, thereby limiting business growth and resource optimization.

Innovative Solutions with AI

Allen Terleto, VP Global Partners and Ecosystem at Cockroach Labs, expressed enthusiasm about the collaboration, stating, "We're excited to deepen our relationship with AWS to streamline and reduce the risks associated with .NET application modernization. Our partnership aims to empower developers by providing the necessary tools to create scalable, resilient applications that take full advantage of AWS's infrastructure. CockroachDB's capabilities will facilitate seamless database migration and integrate well with legacy RDBMS features, allowing developers to harness cloud-native benefits effectively."

Customer Success Stories

Customers of Cockroach Labs, such as Route, illustrate the effectiveness of their solutions. Route recognized the importance of implementing a distributed cloud database to support their critical operations, which included managing over 1 billion orders. By migrating to CockroachDB on AWS, Route ensured continuous data availability and improved system resilience.

Embracing Cloud-Native Architecture

The partnership between Cockroach Labs and AWS provides enterprises with a comprehensive solution to modernize legacy applications fully. Through success stories and robust tools like Amazon Q Developer, organizations can accelerate their modernization journeys and transition to modern, always-on cloud-native applications, bolstered by CockroachDB's inherent resilience and performance capabilities.

Why Choose CockroachDB?

CockroachDB is designed to scale effortlessly while providing robust performance, making it perfect for any mission-critical workload. By modernizing with CockroachDB on AWS, businesses can ensure they are equipped to handle increasing data demands while lowering operational costs and enhancing their responsiveness to market changes.

About Cockroach Labs

Cockroach Labs operates at the cutting edge of database technology and is committed to delivering scalable and resilient solutions for critical business needs. Their innovative distributed SQL database, CockroachDB, has been instrumental for clients such as Bose, Form3, and Shipt, helping them modernize their data management strategies and stay competitive in fast-paced industries. The mission of Cockroach Labs is clear: to provide systems that scale seamlessly, even when faced with the challenges of high demand and complex data environments.

Frequently Asked Questions

What is the primary focus of the collaboration between Cockroach Labs and AWS?

The collaboration aims to modernize Windows-based applications dependent on monolithic legacy databases using AI-powered transformation tools.

How does CockroachDB facilitate database migration?

CockroachDB offers seamless compatibility with legacy RDBMS features and enhances scalability, making it easier for enterprises to migrate their data with minimal disruption.

Who are some clients that have benefited from CockroachDB?

Notable clients include Route, Bose, Form3, and Shipt, showcasing CockroachDB's ability to meet the demands of mission-critical workloads.

What are the advantages of using cloud-native architecture?

Cloud-native architecture promotes better scalability, often reducing costs and improving performance through distributed systems designed for modern data requirements.

How can companies get started with CockroachDB on AWS?

Businesses interested in trying CockroachDB can visit the Cockroach Labs website to explore the offerings and begin their modernization journey.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 74

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 186

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 193

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
Advanta's Game-Changer: Acquiring Misr Hytech to Expand in Africa

Updated Category News Views 218

Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 166

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 255

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
BETR's Slide: Investors Face Big Losses, Leadership Shift

Updated Category News Views 129

BETR Investors Left in the Lurch It's a real trainwreck, folks. Better Home & Finance Holding Company, trading under NASDAQ:BETR, is in the spotlight for all the wrong reasons. The company expanded the class period for its investor lawsuit to include even more dates between March and August 2026, reflecting a torturous ride for shareholders. Their stock cratered by a...

Continue Reading
HiTHIUM Joins Cambridge to Boost Global Energy Storage

Updated Category News Views 372

HiTHIUM and Cambridge's New Energy Venture There's a big splash coming out of Xiamen, folks. HiTHIUM, a heavyweight in the energy storage sector, has decided to team up with the University of Cambridge. They inked a deal aiming to bridge the academic ivory tower with industrial grit, focusing on long-duration energy storage. It was all sealed during the Global Energy...

Continue Reading
LaserAway Expands to 244 Clinics Over 20 Years

Updated Category News Views 203

A Milestone in Aesthetic Dermatology Twenty years, folks. That's a long haul for most businesses, let alone one in the fickle field of aesthetic dermatology. LaserAway, the juggernaut in this arena, has just opened its 244th clinic at 6300 Kingery Hwy in Willowbrook, IL. Nothing to be sneezed at. Imagine running a business, let alone one that's been amping up aesthetic...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 115

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading

Top 5 Most Recently Viewed Articles

BioSig Technologies Updates on Merger and Share Issuance Plans

Updated Category News Views 173

BioSig Technologies Provides Merger Update LOS ANGELES and VANCOUVER, British Columbia — BioSig Technologies, Inc. (NASDAQ: BSGM), recently provided a significant update regarding its merger with Streamex Exchange Corporation. The recent developments aim to clarify the status of the merger and ensure all shareholders are informed. Details of the Merger Finalization The...

Continue Reading
De La Rue plc: Key Information on Recent Trading Activities

Updated Category News Views 138

Overview of Recent Trading Activities De La Rue plc has recently made headlines through significant trading activities that reflect its status as a leading player in the security printing and cash management industry. As a key participant in financial and currency-related services, the company often finds itself at the crossroads of public interest and regulatory...

Continue Reading
Spar Nord's Strong Financial Performance in Q1 2025

Updated Category News Views 373

Spar Nord Reports Positive Q1 2025 Financial Results Profit after tax of DKK 491 million and return on equity of 14.0% Spar Nord has kicked off 2025 with a robust profit after tax of DKK 491 million, demonstrating a notable return on equity of 14.0%. While this performance marks a promising start for the year, it has been influenced by declining interest rates impacting...

Continue Reading
Latest Trends in CEO Confidence and Economic Outlook

Updated Category News Views 260

CEO Confidence Insights for Q4 2025 The Conference Board, in partnership with The Business Council, reported a slight decrease in the CEO Confidence measure, which now stands at 48 in the fourth quarter of 2025. This reflects a one-point drop from 49 during the third quarter. The readings below 50 indicate a dominantly negative sentiment among executives. In total, 130...

Continue Reading
Shift in Options Trading: Is Tesla Gaining Momentum Over Nvidia?

Updated Category News Views 301

Shift in Options Trading Dynamics The S&P 500 experienced a modest increase, climbing by around 20 basis points, while the NASDAQ 100 saw a more substantial rise, soaring by an impressive 80 basis points. A significant contributor to this market movement was none other than Tesla (NASDAQ: TSLA), which experienced a remarkable surge of about 20% in its stock price....

Continue Reading